BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6825083)

  • 1. Biochemical and antitumor effects of 5,8-dideazaisopteroylglutamate, a unique quinazoline inhibitor of thymidylate synthase.
    Fernandes DJ; Bertino JR; Hynes JB
    Cancer Res; 1983 Mar; 43(3):1117-23. PubMed ID: 6825083
    [No Abstract]   [Full Text] [Related]  

  • 2. A potent antitumour quinazoline inhibitor of thymidylate synthetase: synthesis, biological properties and therapeutic results in mice.
    Jones TR; Calvert AH; Jackman AL; Brown SJ; Jones M; Harrap KR
    Eur J Cancer (1965); 1981 Jan; 17(1):11-9. PubMed ID: 7262141
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of 5,8-dideazaisopteroylglutamate and its possible tri-gamma-glutamyl metabolite (5,8-dideazaisoPteGlu3) on colon adenocarcinoma, and the folate dependent enzymes thymidylate synthase and dihydrofolate reductase.
    Fernandes DJ; Cardenas RM; Bertino JR; Hynes JB
    Adv Exp Med Biol; 1983; 163():341-57. PubMed ID: 6688493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of thymidylate synthetase by the new quinazoline antifolate, CB 3717; enzyme purification and kinetics.
    Jackman AL; Calvert AH; Hart LI; Harrap KR
    Adv Exp Med Biol; 1984; 165 Pt B():375-8. PubMed ID: 6720434
    [No Abstract]   [Full Text] [Related]  

  • 5. Cellular pharmacology and in vivo activity of a new anticancer agent, ZD9331: a water-soluble, nonpolyglutamatable, quinazoline-based inhibitor of thymidylate synthase.
    Jackman AL; Kimbell R; Aherne GW; Brunton L; Jansen G; Stephens TC; Smith MN; Wardleworth JM; Boyle FT
    Clin Cancer Res; 1997 Jun; 3(6):911-21. PubMed ID: 9815766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinazoline antifolates as inhibitors of growth, dihydrofolate reductase, and thymidylate synthetase of mouse neuroblastoma cells in culture.
    Carlin SC; Rosenberg RN; VandeVenter L; Friedkin M
    Mol Pharmacol; 1974 Mar; 10(2):194-203. PubMed ID: 4546895
    [No Abstract]   [Full Text] [Related]  

  • 7. The duration of the inhibition of thymidylate synthase in intact L1210 cells exposed to two different classes of quinazoline analogues.
    Kimbell R; Jackman AL; Boyle FT; Hardcastle A; Aherne W
    Adv Exp Med Biol; 1993; 338():597-600. PubMed ID: 8304189
    [No Abstract]   [Full Text] [Related]  

  • 8. Structure-based design of lipophilic quinazoline inhibitors of thymidylate synthase.
    Jones TR; Varney MD; Webber SE; Lewis KK; Marzoni GP; Palmer CL; Kathardekar V; Welsh KM; Webber S; Matthews DA; Appelt K; Smith WW; Janson CA; Villafranca JE; Bacquet RJ; Howland EF; Booth CL; Herrmann SM; Ward RW; White J; Moomaw EW; Bartlett CA; Morse CA
    J Med Chem; 1996 Feb; 39(4):904-17. PubMed ID: 8632414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemical and cellular pharmacology of 1843U89, a novel benzoquinazoline inhibitor of thymidylate synthase.
    Duch DS; Banks S; Dev IK; Dickerson SH; Ferone R; Heath LS; Humphreys J; Knick V; Pendergast W; Singer S
    Cancer Res; 1993 Feb; 53(4):810-8. PubMed ID: 8428362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The antitumour activity of ZD9331, a non-polyglutamatable quinazoline thymidylate synthase inhibitor.
    Jackman AL; Kimbell R; Brown M; Brunton L; Harrap KR; Wardleworth JM; Boyle FT
    Adv Exp Med Biol; 1994; 370():185-8. PubMed ID: 7660886
    [No Abstract]   [Full Text] [Related]  

  • 11. Quinazoline thymidylate synthase inhibitors: methods for assessing the contribution of polyglutamation to their in vitro activity.
    Jackman AL; Kimbell R; Brown M; Brunton L; Boyle FT
    Anticancer Drug Des; 1995 Oct; 10(7):555-72. PubMed ID: 7495479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinazoline analogues of folic acid as inhibitors of thymidylate synthetase from bacterial and mammalian sources.
    Scanlon KJ; Moroson BA; Bertino JR; Hynes JB
    Mol Pharmacol; 1979 Jul; 16(1):261-9. PubMed ID: 113660
    [No Abstract]   [Full Text] [Related]  

  • 13. Quinazoline antifolates inhibiting thymidylate synthase: computer modelling of the N10 substituent.
    Jones TR; Betteridge RF; Neidle S; Jackman AL; Calvert AH
    Anticancer Drug Des; 1989 Mar; 3(4):243-8. PubMed ID: 2930626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma nucleoside and base levels following treatment with the new thymidylate synthetase inhibitor CB 3717.
    Taylor GA; Jackman AL; Calvert AH; Harrap KR
    Adv Exp Med Biol; 1984; 165 Pt B():379-82. PubMed ID: 6720435
    [No Abstract]   [Full Text] [Related]  

  • 15. BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors.
    Gibbs DD; Theti DS; Wood N; Green M; Raynaud F; Valenti M; Forster MD; Mitchell F; Bavetsias V; Henderson E; Jackman AL
    Cancer Res; 2005 Dec; 65(24):11721-8. PubMed ID: 16357184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody-directed enzyme prodrug therapy with the T268G mutant of human carboxypeptidase A1: in vitro and in vivo studies with prodrugs of methotrexate and the thymidylate synthase inhibitors GW1031 and GW1843.
    Wolfe LA; Mullin RJ; Laethem R; Blumenkopf TA; Cory M; Miller JF; Keith BR; Humphreys J; Smith GK
    Bioconjug Chem; 1999; 10(1):38-48. PubMed ID: 9893962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of Cyclopenta[g]quinazoline-based antifolates as inhibitors of thymidylate synthase and potential antitumor agents(,).
    Bavetsias V; Marriott JH; Melin C; Kimbell R; Matusiak ZS; Boyle FT; Jackman AL
    J Med Chem; 2000 May; 43(10):1910-26. PubMed ID: 10821704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initiatives with platinum- and quinazoline-based antitumor molecules--Fourteenth Bruce F. Cain Memorial Award Lecture.
    Harrap KR
    Cancer Res; 1995 Jul; 55(13):2761-8. PubMed ID: 7796401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quinazoline antifolate thymidylate synthase inhibitors: gamma-linked L-D, D-D, and D-L dipeptide analogues of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid (ICI 198583).
    Bavetsias V; Jackman AL; Kimbell R; Gibson W; Boyle FT; Bisset GM
    J Med Chem; 1996 Jan; 39(1):73-85. PubMed ID: 8568829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new antitumour agent, batracylin, selected by a preclinical solid tumour model.
    Atassi G; Dumont P; Kabbe HJ; Yoder O
    Drugs Exp Clin Res; 1988; 14(9):571-4. PubMed ID: 3229319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.